SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-10-094362
Filing Date
2010-04-27
Accepted
2010-04-27 11:43:02
Documents
4
Effectiveness Date
2010-04-27

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS ddefa14a.htm DEFA14A 25360
2 GRAPHIC g57647notice_pg01.jpg GRAPHIC 99712
3 GRAPHIC g57647notice_pg02.jpg GRAPHIC 167441
4 GRAPHIC g57647notice_pg03.jpg GRAPHIC 35593
  Complete submission text file 0001193125-10-094362.txt   444462
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-19756 | Film No.: 10772362
SIC: 2836 Biological Products, (No Diagnostic Substances)